Total Payments
$183,699
2024 Payments
$70,866
Companies
42
Transactions
1,345
Medicare Patients
12,613
Medicare Billing
$939,929
Payment Breakdown by Category
Other$120,851 (65.8%)
Food & Beverage$24,539 (13.4%)
Consulting$23,310 (12.7%)
Travel$14,421 (7.9%)
Education$577.52 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $120,820 | 52 | 65.8% |
| Food and Beverage | $24,539 | 1,216 | 13.4% |
| Consulting Fee | $23,310 | 9 | 12.7% |
| Travel and Lodging | $14,421 | 38 | 7.9% |
| Education | $577.52 | 29 | 0.3% |
| Honoraria | $30.87 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $62,894 | 189 | $0 (2024) |
| Galderma Laboratories, L.P. | $30,354 | 138 | $0 (2024) |
| Amgen Inc. | $29,143 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $26,850 | 76 | $0 (2024) |
| ABBVIE INC. | $14,591 | 203 | $0 (2024) |
| GENZYME CORPORATION | $6,781 | 83 | $0 (2024) |
| Janssen Biotech, Inc. | $2,833 | 88 | $0 (2024) |
| UCB, Inc. | $1,617 | 29 | $0 (2024) |
| Dermavant Sciences, Inc. | $1,385 | 61 | $0 (2024) |
| Lilly USA, LLC | $1,202 | 78 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,866 | 305 | Amgen Inc. ($21,378) |
| 2023 | $15,625 | 192 | Amgen Inc. ($7,628) |
| 2022 | $13,948 | 137 | PFIZER INC. ($11,708) |
| 2021 | $6,356 | 64 | Novartis Pharmaceuticals Corporation ($5,388) |
| 2020 | $1,568 | 34 | PFIZER INC. ($857.93) |
| 2019 | $23,491 | 191 | PFIZER INC. ($14,034) |
| 2018 | $40,368 | 232 | PFIZER INC. ($16,951) |
| 2017 | $11,477 | 190 | Galderma Laboratories, L.P. ($9,089) |
All Payment Transactions
1,345 individual payment records from CMS Open Payments — Page 1 of 54
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.11 | General |
| 12/19/2024 | Galderma Laboratories, L.P. | — | Travel and Lodging | In-kind items and services | $102.14 | General |
| 12/19/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: DERMATOLOGY | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $87.84 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: Immunology | ||||||
| 12/16/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Inflammation & Immunology | ||||||
| 12/13/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $10.09 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $16.93 | General |
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Dermatology | ||||||
| 11/25/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,725.00 | General |
| Category: Inflammation & Immunology | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Immunology | ||||||
| 11/25/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.32 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $6.68 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $1.72 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,192 | 5,876 | $906,341 | $244,954 |
| 2022 | 26 | 3,328 | 6,035 | $917,041 | $251,671 |
| 2021 | 24 | 3,147 | 5,699 | $889,843 | $248,641 |
| 2020 | 22 | 2,946 | 4,725 | $783,107 | $194,664 |
Total Patients
12,613
Total Services
22,335
Medicare Billing
$939,929
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 792 | 1,153 | $145,278 | $69,951 | 48.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 599 | 822 | $192,348 | $31,360 | 16.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 246 | 293 | $92,881 | $21,392 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 241 | $45,067 | $20,557 | 45.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 79 | 91 | $81,081 | $20,089 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 242 | 242 | $45,738 | $18,712 | 40.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 245 | 262 | $74,408 | $14,254 | 19.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 432 | 2,335 | $49,035 | $10,967 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $20,079 | $7,414 | 36.9% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 31 | 32 | $28,640 | $7,113 | 24.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 36 | 40 | $28,680 | $3,766 | 13.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 32 | 34 | $27,744 | $3,665 | 13.2% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $11,037 | $3,102 | 28.1% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 29 | 30 | $23,730 | $3,098 | 13.1% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 17 | $8,670 | $1,939 | 22.4% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 11 | 15 | $9,045 | $1,920 | 21.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 48 | $7,392 | $1,662 | 22.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 28 | 31 | $2,356 | $1,262 | 53.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $2,990 | $1,123 | 37.6% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $5,664 | $792.60 | 14.0% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 14 | $4,242 | $770.64 | 18.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 12 | 59 | $236.00 | $43.83 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 797 | 1,161 | $146,349 | $72,190 | 49.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 582 | 813 | $190,242 | $31,250 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 252 | $47,124 | $22,492 | 47.7% |
About Dr. Frank Morocco, D.O
Dr. Frank Morocco, D.O is a Dermatology healthcare provider based in Marion, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2009. The National Provider Identifier (NPI) number assigned to this provider is 1659508018.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frank Morocco, D.O has received a total of $183,699 in payments from pharmaceutical and medical device companies, with $70,866 received in 2024. These payments were reported across 1,345 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($120,820).
As a Medicare-enrolled provider, Morocco has provided services to 12,613 Medicare beneficiaries, totaling 22,335 services with total Medicare billing of $939,929. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Marion, OH
- Active Since 06/12/2009
- Last Updated 12/15/2021
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1659508018
Products in Payments
- EUCRISA (Drug) $30,529
- CIBINQO (Drug) $30,332
- Otezla (Drug) $29,423
- COSENTYX (Biological) $20,165
- SKYRIZI (Biological) $12,366
- EPIDUO FORTE (Drug) $11,734
- ORACEA (Drug) $4,373
- MIRVASO (Drug) $4,372
- DUPIXENT (Biological) $4,269
- TREMFYA (Drug) $2,215
- VTAMA (Drug) $1,385
- RINVOQ (Biological) $1,033
- TALTZ (Drug) $834.16
- Humira (Biological) $826.56
- SOOLANTRA (Drug) $515.40
- STELARA (Biological) $388.70
- Sotyktu (Drug) $380.57
- DERMATITIS - DISEASE (Drug) $311.94
- Winlevi (Drug) $278.64
- OPZELURA (Drug) $264.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.